Skip to main content
Download PDF

Kupffer cells abrogate homing and repopulation of allogeneic hepatic progenitors in injured liver site

Stem Cell Research & Therapy volume 15, Article number: 48 (2024) Cite this article

Abstract

Background

Allogeneic hepatocyte transplantation is an emerging approach to treat acute liver defects. However, durable engraftment of the transplanted cells remains a daunting task, as they are actively cleared by the recipient’s immune system. Therefore, a detailed understanding of the innate or adaptive immune cells-derived responses against allogeneic transplanted hepatic cells is the key to rationalize cell-based therapies.

Methods

Here, we induced an acute inflammatory regenerative niche (3–96 h) on the surface of the liver by the application of cryo-injury (CI) to systematically evaluate the innate immune response against transplanted allogeneic hepatic progenitors in a sustained micro-inflammatory environment.

Results

The resulting data highlighted that the injured site was significantly repopulated by alternating numbers of innate immune cells, including neutrophils, monocytes and Kupffer cells (KCs), from 3 to 96 h. The transplanted allo-HPs, engrafted 6 h post-injury, were collectively eliminated by the innate immune response within 24 h of transplantation. Selective depletion of the KCs demonstrated a delayed recruitment of monocytes from day 2 to day 6. In addition, the intrasplenic engraftment of the hepatic progenitors 54 h post-transplantation was dismantled by KCs, while a time-dependent better survival and translocation of the transplanted cells into the injured site could be observed in samples devoid of KCs.

Conclusion

Overall, this study provides evidence that KCs ablation enables a better survival and integration of allo-HPs in a sustained liver inflammatory environment, having implications for rationalizing the cell-based therapeutic interventions against liver defects.

Background

A key pathological feature of the overwhelming liver damage is the massive mobilization of innate and adaptive immune responses leading to acute liver failure [1, 2]. Therapeutically, liver replacement, also known as orthotopic liver transplantation (OLT), remains an essential curative therapy for acute liver failure and end-stage liver injuries [3,4,5]. However, emerging data indicate that transplantation of healthy hepatocytes in acute and chronic liver failures may substitute the OLT in clinical practice [6,7,8,9,10].

Over the last decade, allogeneic hepatocyte transplantation has actively been pursued as an alternative approach to OLT for the cure of liver-based metabolic defects and acute liver failure [11, 12]. Although encouraging clinical benefits have been observed in patients receiving allogeneic hepatocyte transplantation [13, 14], durable engraftment of the transplanted cells despite using immunosuppression has not yet been achieved [13]. Generally, it is considered that a Kupffer cells (KCs)-derived pronounced hindrance is offered during the translocation of the transplanted cells from the portal spaces into the site of integration at the liver parenchyma, leading to their elimination [15,16,17]. It has also been reported that the exogenous transplanted cells are recognized by activated instant blood-mediated inflammatory reaction [18,19,20,21,22], in combination with cytokines and chemokines primarily derived from neutrophils and KCs [15, 23]. Recent experimental evidence suggests that survival of the cellular allograft is limited by multiple barriers, including the endothelial lining of the sinusoids and immune rejection followed by spontaneous apoptosis [24,25,26,27,28].

A general drawback associated with cell-based therapies is the limited capacity of transplanted cells to repopulate, as of being unable to proliferate, in the normal liver and, thus, are actively cleared by the recipient immune system [28, 29]. For instance, a previous study by Joseph et al. [15] claimed that almost 70–80% of the transplanted syngeneic hepatocytes were immediately eliminated by the initial innate immune response, while it posed a significant hurdle for the remaining ones to be located and screened for biological activity and repopulation efficiency in the recipient's liver [30]. Given this fact, whether the innate immune cells, particularly the KCs, respond against allogeneic transplanted hepatic progenitors (allo-HPs), in the context of sustained liver inflammation, is not yet clearly defined.

Herein, by recapitulating the previously established protocol [31], we have generated allogeneic hepatic progenitors (allo-HPs) from adult hepatocytes isolated from BALB/c mice. These progenitors were then intrasplenically engrafted into C57BL/6 wild-type mice while inducing selective damage to their hepatic parenchyma. Our results indicate that a deleterious initial blood-mediated innate immune response, mainly governed by KCs, is instigated against the transplanted allo-HPs. By in vivo depletion of neutrophils and KCs, we further demonstrate that KCs ablation supports the viability of the allo-HPs that later translocated from portal spaces and repopulated at the injured site along with the hepatic stellate cells (HSCs). In brief, the findings reported in this study could be helpful for the rational optimization of transient cell-based therapies being evaluated in the context of sustained innate inflammatory response.

Methods

Ethical statement

Animal procedures were performed in the animal house facility of Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS). All experimental procedures were approved by the ethical committee of GIBH (ethical process number: N2014050) and performed under the guidelines of the Guangdong Provincial Department of Science and Technology for Animal Welfare. Further, the animal studies are reported in compliance with ARRIVE guidelines. All efforts were made to ensure minimal animal suffering.

Animal source

Female C57BL/6 and BALB/c mice, six to eight weeks old were purchased from Vital River Laboratory Animal Technology Co. (Beijing). For in vivo experiments, 90 mice were randomized into 30 experimental and control groups with 3 mice each (n = 3) The sample size was determined based on our and previous studies [32, 33]. All mice (4–5 per cage) were housed in a 12-h light/12-h dark cycle and were raised in pathogen-free grade cages in a temperature-controlled, sterile animal facility with free access to food and water.

Induction of cryo-injury

For in vivo experiments, cryo-injury (CI) procedure was conducted as previously described [34]. Briefly, a midline laparotomy was performed under tribromoethanol (TBE) anesthesia in 0.9% of saline, and the left lobe of the liver was exposed. A metallic probe was immersed in liquid nitrogen and was carefully placed on the exposed lobe to achieve a 0.5 cm long lesion on the surface of the liver. The abdominal cavity was closed, and mice were recovered at 37 °C. Conversely, the animals in the sham/control group underwent the same procedure or sham injury (SI), except that the exposed liver was treated with a metallic probe set at room temperature. Animals were excluded from the study if any abnormal behavioral signs and/or ≥ 20% loss of body weight were observed. Mice were anesthetized by intraperitoneal (I.P) injection of TBE and were killed under specified intervals of time post-injury. In fact, the rationale behind selecting the Cryo-injury model for our study stems from the need to address limitations associated with conventional injury models (like BDL, CCl4, and APAP). These traditional models often induce widespread liver damage, which can impede the focused study of immune cell interactions with transplanted cells. In contrast, the Cryo-injury model creates a predetermined and marked injury loci, providing a unique feature for tracing the consequential events including the immune response and its impact on transplanted cells in a spatial–temporal manner.

Assessment of cytokines by ELISA

Mice were anesthetized and blood samples were obtained by cardiac puncture and were collected either in a K3 EDTA vacutainer (cat# 367,861, BD) or in  an Eppendorf tube. Samples were centrifuged at 2000 RPM for 20 min and blood plasma was collected as supernatant, aliquoted and stored at—80 °C for downstream analyses. Standard procedures were followed according to the manufacturer’s instructions and blood cytokines levels were analyzed by standard ELISA kits for IFNγ (cat#: MIF00, R&D), IL-6 (cat #: M6000B) and IL-10 (cat#: BMS614-2). In addition, MCP-1 (Cat# AF-479, R&D) levels were analyzed by Western blotting.

RNA isolation and gene expression analyses

Total RNA was extracted using TRIzol reagent (Invitrogen) from flash-frozen samples according to the manufacturer’s protocol. The isolated RNA was quantified (NanoDrop 2000—Thermos Fischer) was reverse transcribed into cDNA from 2 µg RNA using Revertra Ace (Toyobo) and oligo-dt (Takara). Quantitative RT-PCR was performed with the CFX96 and SYBR Green Premix system (Bio-Rad) following the manufacturer’s recommendations. The relative mRNA expression of the analyzed gene in all cases was normalized to β-actin, and each experiment was repeated thrice for validation. The primer sequences used in this study are mentioned Additional file 1: Table S1.

ALT/AST assessment and histology

Serum levels of alanine aminotransferase (ALT) and aspartate transaminase (AST) were measured using a standard clinical automated analyzer (SRL, Tokyo, Japan). For histology, liver samples were harvested and washed with ice-cold PBS and were immediately fixed in 10% neutral buffered formalin for 24 h. Paraffin sections were stained with conventional hematoxylin and eosin (H&E) staining and examined.

Immunohistochemistry and immunofluorescence

Mice were anesthetized and liver samples were collected and washed with ice-cold PBS. Harvested liver samples were either embedded in an optimum-cutting temperature (OCT) medium for cryostat section (7 µm) or fixed in 10% neutral buffered formalin 24 h for paraffin section (4 µm). Sections were incubated with 10% fetal bovine serum (FBS) for non-specific binding for 1 h at room temperature. Primary antibodies [anti-F4/80 (1:50; Bio-Rad: #MCA497, anti-CD11b (1:100; BD: # 550282), anti-CD45 (1:200; BD: # 550539), anti-Ly6G (1:150; Abcam: # ab25377), and αSMA (1:900; Abcam: # ab124964)] were diluted in 10% FBS and were incubated for 2 h at room temperature. Sections were washed with PBS and signals were amplified by secondary antibodies [ImmPRESS-HRP anti-rabbit IgG (Vector Labs # MP-7401) or ImmPRESS-AP anti-rat IgG (Vector Labs: # MP-5444)] for 40 min at room temperature. Immunogenic reaction was visualized by Alkaline Phosphatase (AP) Substrate (Vector Labs: # SK-5105), ImmPACT Vector Red Alkaline reagent (Vector Labs: # SK-5105) or DAB (Zsbio: # ZLI-9018) or with DAPI (1:2000) and mounted. All IHC images were quantified with ImageJ (NIH) in 5 random views at 40 × magnification as percentage of positive pixels in a blinded fashion.

Induction of hepatic progenitors from primary mouse hepatocytes

Mouse HPs were generated as previously described [31]. Briefly, primary adult mice hepatocytes were isolated from 8 to 12 weeks old female BALB/c mice by two-step perfusion method. After perfusion with Ca+2 free Hank’s/EGTA solution and digestion with collagenase solution (Millipore Sigma), the digested livers were filtered and the suspension was collected via centrifugation at 50 g at 4 °C. Dead cells were removed, the remaining cells were washed twice and cultured with small hepatocytes basal medium (SHM) [DMEM/F12 (high glucose, Hyclone) supplemented with 5 mM HEPES (Sigma), 10 ng epidermal growth factor (PeproTech), 1% ITS (Gibco), 30 mg/L L-proline (Sigma), 0.05% BSA (Gibco), 10–7 M dexamethasone (Dex) (Selleck), 1 mM ascorbic acid, 10 mM nicotinamide (Stem Cell), and 1% penicillin and streptomycin solution (Life Technologies)] supplemented with 10% FBS (Gibco). Purified mouse hepatocytes were then seeded on collagen-coated plates in SHM with or without the combination of the small molecule inhibitors, Y-27632 (Selleck), 0.5 mM A-83–01 (Selleck) and CHIR99021 (Selleck). One day after seeding, the medium was changed and every other day thereafter. We confirmed all procedures for hepatic and biliary functions described for mouse hepatic progenitors as mentioned in [31].

Luciferase reporter gene assay

Lenti-Combo Packing Mix (Cosmobio) and the expression construct pCDH-CMV-MCS-EF1-Greenpuro (System Biosciences, Mountain View, CA) were transfected into HEK293T cells to create lentiviral vectors (Clontech). The luciferase gene (GL3) (Promega) was inserted into the MCS of the expression construct. The culture medium was replaced with SHM + YAC a day after transfection. The clones were treated with collected lentiviruses two days later. Cells that had been transduced with GFP were chosen in SHM + YAC containing 2 g/mL puromycin (Life Technologies).

Transplantation of allo-HPs

Wild-type C57BL/6 female mice were used as recipients for the hepatic transplantation of the allo-HPs. Liver was preconditioned with Clodronate liposomes (CLs) or PBS liposomes (PLs) before treatment(s). Acute liver damage was induced by CI in 6–8 weeks old mice 24 h post-PLs/CLs treatment(s). One to two days post-Cl, allo-HPs (1 × 106) were intrasplenically transplanted into the recipient mice. For the experiments involving cell depletions, we established an internal experimental group. Animals under these groups underwent cryo-injury followed by transplantation of allogeneic hepatic progenitors (allo-HPs) but without any cell depletion inventions. These groups either receive phosphate-buffered saline liposomes (PLs) or isotype-Ly6G. In comparison, the external experimental groups, which were referred to as sham groups in our study, were established to provide a baseline reference for comparison. The animals in these groups underwent sham injury (SI) followed by allo-HPs without undergoing any cell depletion procedures. Samples were collected at specified time intervals, and GFP-tagged transplanted cells were monitored by confocal microscopy in liver samples. Further, to minimize the possibility of experimenter bias, the investigator who conducted the experiment was not aware of the treatment procedure.

Kupffer cells and neutrophils depletion

CLs or PLs were prepared as previously described [35], and used for the depletion of KCs. Liposomes were brought to room temperature for 30 min before injection. The tail vein was sterilized with 75% ethanol. Intravenous injections of the CLs or PLs, according to the manufacturer’s instructions, were injected into 6–8 weeks old female C57BL/6 mice 24 h before inducing CI. Mice were killed under anesthesia and samples were collected after a specified interval of time. KCs depletion was confirmed by immunohistochemical staining of the sections with KCs specific marker F4/80. Considering the observed poor expression of CLEC4F on Kupffer cells in various models of liver inflammation and injuries, such as NASH [36,37,38] and LPS [39], coupled with the documented loss of CLEC4F expression in primary Kupffer cell cultures and the complete absence of CLEC4F expression in the Kupffer cell line [40, 41], we have chosen to utilize the F4/80 marker. F4/80 is recognized as the most widely used marker for Kupffer cells, as supported by landmark studies [42, 43]. The ultimate aim was to minimize the risk of misidentifying Kupffer cells in the context of our injury model.

Neutrophils were depleted 24 h before CI by a single intraperitoneal injection of 400 µg of anti-Ly6G (clone 1A8, BioXCell), as previously described [44]. To reduce the experimenter bias, the researcher was blind to the treatment procedure. Mice were killed under anesthesia and liver samples were collected as specified. Neutrophils depletion was confirmed by IHC staining of anti-Ly6G (Cat# 25377, 1:150, Abcam), a granulocyte-specific marker.

Western blotting

Western blot was performed as previously described [45]. Briefly, sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) of the extracted proteins from the injured site was subsequently blotted using anti-CCL2/MCP1 (Cat# AF-479, R&D) and  anti-GAPDH (Cat # 600041-I-Ig, Proteintech) antibodies.

Statistical analyses

Statistical analysis was conducted using GraphPad Prism 7.0 software (GraphPad Prism Software Inc., San Diego, CA, USA). To determine the significance of differences between groups, Student's t-test or one-way analysis of variance (ANOVA) was employed. Statistical significance was denoted by *, **, ***, and ****, indicating P-values less than 0.05, 0.01, 0.001, and 0.0001, respectively. The data are presented as mean ± standard deviation. Representative results from three independent experiments are displayed.

Results

Characteristics of CI-induced hepatic inflammatory-and-regenerative niche

We used our previously reported CI protocol [34] to establish a localized niche as a regenerative stimulus for the subsequent homing and repopulation of the transplanted hepatic progenitors. Figure 1A shows the experimental design and sample(s) collection at various time intervals after induction of cryo-injury. We detected a rapid onset of localized hepatic tissue damage, as characterized by conventional H&E stain (Fig. 1B) and TUNEL assay (Fig. 1C). The maximum induction of histological necrosis was significantly observed after 12 h of CI-induced hepatic damage (Fig. 1D). At the molecular level, the plasma levels of AST and ALT increased sharply and reached their peak level at 12 h after CI which corresponded with the progressed necrosis and tissue damage (Fig. 1E and F). In line with this, the serum levels and gene expression pattern(s) for both pro- and anti-inflammatory cytokines, such as interleukin (IL)-6 and IL-10 respectively, were significantly elevated at early 3 h, although a dramatic decline was observed thereafter (Fig. 1G–J). The monocyte chemoattractant protein-1 (MCP-1) also demonstrated a similar trend at gene expression level (Fig. 1K). However, we observed a consistent expression of MCP-1 at protein level, as indicated by Western blot analysis of samples prepared from liver tissue lysate after CI (Fig. 1L). Collectively, these results suggested that the CI induced the localized regenerative niche in the settings of acute inflammatory response.

Fig. 1
figure 1

Generation of a regenerative niche by cryo-injury (CI). A The experimental design of induction of CI and sample collection at various time intervals is shown. B Representative H&E staining images of the sham and samples after CI. The dotted line indicates the boundary of the healthy and injured liver tissue. C Representative images from TUNEL assay, arrows indicate random necrotic hepatocytes after CI. D TUNEL staining was quantified by counting apoptotic hepatic nuclei in 5 random views at 40 × magnification as shown at indicated time intervals. Data are presented as mean ± SD, *p < 0.05, **p < 0.01 ***p < 0.001, n = 3/24 for each time point, scale bars: 100 µm. E, F Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) analyses from mice with or without CI. G, H Interleukin-6 (IL-6) ELISA and IL-6 mRNA gene expression from the injured and non-injured liver is represented. I, J Interleukin-10 (IL-10) ELISA and IL-10 mRNA gene expression levels are shown. K, L Monocyte chemoattractant protein—1(MCP-1) mRNA gene expression and representative cropped immunoblot analyses from injured liver tissues, respectively. The corresponding full length immunoblot can be found in supplementary figure S4. Data represented as mean ± SD, *p < 0.05, **p < 0.01 ***p < 0.001, ****p < 0.0001., n = 3/24 per time point

Full size image

Granulocytes and monocytes selectively repopulate at the injured site

The timely recruitment of blood-derived immune cells, such as neutrophils and monocytes, is the key feature of inflammatory response [46, 47]. Consistent expression of MCP-1 (Fig. 1L), which is a primary mediator of immune cells recruitment at the injured site [48], prompted us to enquire whether there is the infiltration of blood-derived granulocytes and monocytes at the injured site. To examine this, we performed an IHC analysis of liver tissue samples with a pan-CD45 marker. The results indicated that the CD45 + leukocytes began to infiltrate the injured site within 3-6 h, subsequently occupying the injured site from 12 to 24 h, and then gradually enriched at the proximity of the injured border (Fig. 2A). We next conducted an IHC analysis to determine the infiltration of neutrophils and monocytes into the injured site. Interestingly, neutrophil (Ly6G +) swarms were significantly detected into the injured site from 12 to 24 h post-CI (Fig. 2B, C). However, the overall neutrophil infiltration subsided soon after 24 h and only few cells could be observed after 48 h post-CI as compared to sham control (Fig. 2B, C). Likewise, a significantly upregulated mRNA expression of Ly6G was detected at 6 h, which gradually declined at the subsequent time intervals (Fig. 2D). In contrast, CD11b staining revealed a gradual, but consistent, infiltration of monocytes from 12 to 96 h (Fig. 2E, F). Overall, there was a parallel infiltration of the neutrophils (Ly6G +) and monocytes (CD11b +) from 3 to 24 h. Nevertheless, in the later time intervals, the patterns of infiltration altered conversely, with a consistent increase in the number of monocytes while a gradual decrease in neutrophils. It demonstrated that the CI recruited neutrophils and monocytes in a sequential manner.

Fig. 2
figure 2

The sequential recruitment of neutrophils and monocytes into the injured site post-CI. A Representative images for pan-CD45 + (leukocytes) cells at specified time points post-CI. The dotted line represents the boundary of the injured site. B Representative IHC staining images of Ly6G + cells at the indicated time intervals. C Quantitation of Ly6G+ cells fields are shown. Ly6G+ cells were quantified in 5 random fields by quantifying positive cells per sample, n = 3/24 per time point. The data were averaged and presented as mean ± SD. **P < 0.01, ****p < 0.0001. D mRNA expression of Ly6G at the injured liver as compared to sham control. E Representative images for CD11b+ immunostaining showing monocyte trafficking at the injured site at the indicated time intervals. F Quantitation of CD11b+ cells per 5 fields is shown. CD11b+ cells are quantified by quantifying positive pixels in 5 random fields, averaged, and presented as mean ± SD of the positive area. n = 3/24 per time point. *p < 0.05, **p < 0.01, ****p < 0.0001. Scale bars 100 µm. Arrows (in B and E) indicate the infiltration of neutrophils (Ly6G+) or monocytes (CD11b+) at 3 h

Full size image

KCs accumulation induce the onset of regenerative responses at the injured site

Emerging evidence indicate that liver parenchymal damage may induce inflammation and repair responses by the activation of KCs [49, 50]. As early as 12 h post-CI, the response timeline analysis for injury indicated that hepatic resident KCs (F4/80 +) started to accumulate near the injured site and seemed to migrate toward and through the injured border line at 48 h post-CI. Moreover, the accumulation of KCs in the injured site was progressively increased from 48 h to 96 h and formed an intensive border fence that separate the injured and non-injured tissue (Fig. 3A, B, inset). Likewise, the elevated gene expression of F4/80 was also detected in a time-dependent manner (Fig. 3C). Since wound repair is the manifestation of trans-differentiated HSCs into collagen-producing myofibroblasts after an injury [51, 52], the αSMA IHC analysis revealed active HSCs appeared in injured site at 24 h post-injury, it was 12 h later compared to appearance of KCs (Fig. 3D, E). However, the migration pattern was in accordance with the accumulation of KCs in later time intervals, but formed a tight border fence. Furthermore, the αSMA gene expression followed a similar trend as was observed with F4/80 at the indicated time intervals (Fig. 3F). Together these results suggest that regenerative responses are preceded by KCs, and the migration and accumulation pattern were followed by the activated HSCs in 12 h later.

Fig. 3
figure 3

KCs accumulation at the injured site induces recruitment of HSCs mediating liver repair response. A Representative IHC images for F4/80+ cells (KCs) at indicated time intervals. Scale bars 100 µm (inset = 50 µm). B, C Quantitation of IHC images of F4/80+ cells, and F4/80 mRNA gene expression, respectively. F4/80 + cells are quantified by quantifying positive pixels in 5 random fields, averaged, and presented as mean ± SD. n = 3/24 per time point. Scale bars 100 µm, n = 3/24 per group. *P < 0.05, ***p < 0.001, and ****p < 0.0001. D Representative IHC images for αSMA expression indicating preliminary activation of HSCs at 24 h and subsequent time intervals. Scale bars 100 µm (inset = 50 µm). E, F Quantitation of αSMA+ cells (quantified by quantifying positive pixels in 5 random fields, averaged, and presented as mean ± SD. n = 3/24 per time point. Scale bars 100 µm, n = 3/24 per group. *P < 0.05, and ****p < 0.0001) and αSMA mRNA gene expression at indicated time intervals, respectively. αSMA mRNA data represented as mean ± SD, ***p < 0.001, and ****p < 0.0001., n = 3/24 per group

Full size image

Depletion of KCs significantly reduces the recruitment of monocytes into the injured site

Monocytes can rapidly extravasate into the inflamed tissue [47], and may conditionally repopulate to regain the lost pool of KCs [53]. To investigate whether modulating KCs activity may affect recruitment and repopulation of the monocytes, we administered 200 μl of either clodronate liposomes (CLs, the experimental group) or PBS liposomes (PLs, the control group) to C57BL/6 WT mice through tail vein in order to eliminate the KCs in liver. The experimental design and sample(s) collection at different time intervals are shown in Fig. 4A. Immunostaining displayed a time-dependent effect of PLs and CLs treatments on the repopulation of KCs at the injured site. Especially, there was a noteworthy accumulation of KCs in case of PLs-treated samples, which gradually increased from day 2 to day 6 (Fig. 4B). However, in the CLs-treated samples, those KCs were absolutely absent from day 2 to day 4 (Fig. 4B), although they emerged as a thin disconnected line in day 6 (Fig. 4B). To further elaborate whether the infiltration and subsequent repopulation of monocytes is dependent on KCs, we detected the localization of monocytes at the injured site by CD11b immunostaining of treated and untreated samples. Overall, a similar pattern of recruitment of monocytes was significantly decreased in day 2—day 6, while the KCs were depleted (Fig. 4C), even though there was a considerable accumulation of monocytes in day 6 of CLs-treated samples, but far less compared to the PLs controls. It indicated that the recruitment and the differentiation of monocytes as KCs are mainly dependent on the recruitment of primary KCs in liver.

Fig. 4
figure 4

Depletion of Kupffer cells (KCs) substantially reduces the recruitment of monocytes from blood. A Experimental design of intravenous injection of either PBS liposomes (PLs) or Clodronate liposomes (CLs), induction of CI procedures and samples collection at specified time intervals. B Representative images of depletion of KCs shown in CLs-treated samples in comparison to PLs-treated and sham sections. KCs after depletion began to reappear at the injury site at day 6 post-CI. C Effect of KCs depletion on monocytes in PLs/CLs-treated samples as compared to sham samples. CLs treatment delayed the recruitment of monocytes, scale bar 100 µm, n = 3/27 per time point

Full size image

KCs hindrance in sinusoid affects the survival of transplanted allo-HPs

Optimal engraftment of transplanted cells yet remains a daunting task [28]. The critical factors associated with the failure of the engraftment of the transplanted cells are mainly attributed to the sinusoidal effects, oxidative stress, and cytokine-mediated toxicity [28]. For instance, a previous study has shown that more than 70% of syngeneic transplanted hepatocytes are eliminated by preliminary innate immune response occurring within 24–48 h in the intact liver. However, being an integral component of the innate immune system, the response of KCs against miss-matched transplanted cells in the inflamed liver is still obscure [28, 29]. To do a preliminary assessment, we determined their post-transplantation hindrance effect on the translocation of allo-HPs from the portal vein to the injured site. We selected similar time points for the transplantation when KCs initiated to accumulate into the injured site (as mentioned in Fig. 3A). The experimental design and time intervals of samples collection are shown in Fig. 5A. The GFP histochemistry analysis at 54 h post-transplantation revealed that allo-HPs can readily be observed in portal areas and periportal spaces as compared to sham samples as mentioned in Fig. 5B, C. Most of the transplanted cells were entrapped in portal areas (enclosed in circles), and periportal liver sinusoids in non-injured site (Fig. 5C, inset). In addition, a cluster of transplanted allo-HPs translocated from portal areas was found to be localized at the vicinity of the invasive edge of the injured site as compared to sham controls (Fig. 5D). We also found that clusters of transplanted allo-HPs were entrapped in the liver plates at the distal end of the healthy site (Fig. 5E). Furthermore, the entrapped transplanted allo-HPs clusters were surrounded by phagocytes/macrophages (F4/80 + cells), which caused diffused fluorescence of the GFP tag and further suggested the preparatory dismantling activity of KCs (Fig. 5E-inset, marked by white arrows). Collectively, these results suggest that KCs hindrance in sinusoids affects the translocation of transplanted allo-HPs in the liver vasculature.

Fig. 5
figure 5

KCs hindrance affects the translocation of allo-HPs in the sinusoids. A Experimental design: CI was induced at day 0 (D0), and GFP tag allo-HPs were engrafted 48 h after induction of CI in wild-type C57 mice. Samples were subsequently collected 54 h post-engraftment. B Representative images of sham-treated liver samples post-transplantation are shown. Scale bars 100 µm (inset = 50 µm). C Transplanted allo-HPs were localized in the portal vein (PV) at the non-injured site. Scale bars 100 µm (inset = 50 µm). D Very few allo-HPs were detected at the vicinity of the injured site. E KCs dismantle allo-HPs in the sinusoids (inset = 50 µm, non-injured site). The arrows indicate KCs invading the clusters of allo-HPs. F Injured site representing KCs (F4/80+) cells. Scale bar 100 µm (inset = 50 µm), n = 3/27

Full size image

KCs ablation and HSCs accumulation support survival and homing of transplanted allo-HPs in the injured site

We next sought to determine whether depletion of KCs affected the fate of the transplanted cells. Based on aforementioned results (in Fig. 5), we hypothesized that KCs might affect the survival of allo-HPs which, in turn, may reduce their homing and subsequent integration into the injured site. To test this, we first partially depleted KCs by intravenous injection of CLs 24 h before induction of CI (Additional file 1: Fig. S1). Allo-HPs were transplanted 48 h after CI and samples were collected post-54 h transplantation (Additional file 1: Fig. S1A). Interestingly, the dual F4/80+ and GFP histochemistry analyses showed that there was no accumulation of translocated allo-HPs into the injured site of the PLs-treated section at 54 h post-transplantation (Additional file 1: Fig. S1B). This probably owes to the expected hindrance effect imposed by KCs (F4/80 stained) that were observed to be linearly accumulated parallel to the injured site (Additional file 1: Fig. S1B), further evident by the detection of allo-HPs at the injured site in CLs-treated sections (Additional file 1: Fig. S1B, inset). The immunostaining analyses also showed that HSCs were considerably located in the CLs-treated samples (see Additional file 1: Fig. S1D, E). This, in addition to suggesting that the presence of HSCs (αSMA+) at the injured site is somehow affected by the presence or absence of KCs, hinted at their possible involvement in the homing of allo-HPs at the injured site.

Transplanted hepatocytes are either immediately cleared by innate immune cells [30], or lose their repopulation efficiency after engraftment [28]. Previous experimental evidence has established that transplanted hepatocytes sense beneficial signals from activated HSCs, which in turn can modulate their engraftment efficiency in rats [54, 55].

Considering this fact and our results from the initial assessment (in Additional file 1: Fig. S1), we questioned whether the accelerated kinetics of allo-HPs from portal spaces into the injured site is the manifestation of the inactivation of KCs with proactive support from the neighboring HSCs. To answer this, we increased the time interval from initial engraftment to sample collection (see Fig. 6A). To our interest, the analyses revealed that while there was a greater accumulation of the KCs 84 h post-transplantation in PLs-treated samples, an enriched prevalence of allo-HPs was observed at the injured site in CLs-treated ones (devoid of KCs) (compare Fig. 6B–D). The allo-HPs were particularly observed at the site of hepatocytes that were bordering the injured site. This hints  at either a paracrine or cell–cell support from the adjoining cellular source (possibly HSCs) that might retain allo-HPs at the injured site. To further elaborate on retention of allo-HPs at the injured site, we collected samples 96 h post-transplantation from PLs- and CLs-treated animals. Again, we found an increased accumulation of HSCs (αSMA+) in PLs sections as compared to CLs-treated sections (Fig. 6E). Of note, the PLs-treated sections remained devoid of traces of allo-HPs in the periphery and at the injured site. Since our transplanted cells were allogeneic, we were expecting a greater immune rejection despite KCs depletion. To our surprise, however, the CLs-treated sections showed a reasonable accumulation and integration of allo-HPs at the injured site (Fig. 6F). The allo-HPs and αSMA+ were observed to mutually adhered as adjoining cell types (Fig. 6F, inset), suggestive of mutual participation to enhance their integration at the injured site.

Fig. 6
figure 6

Engrafted GFP tag allo-HPs repopulating at the border of the injured site. A Experimental design: CI was induced at D0 and samples were collected 84 h or 96 h post-engraftment, respectively. B Representative images of sham-treated samples post-transplantation are shown. C, D PLs- and CLs-treated samples post-84 h of engraftment. CLs-treated samples show repopulation of allo-HPs at the border of injured site as compared to PLs-treated samples. E, F Representative images of engrafted allo-HPs post-96 h of engraftment. CLs-treated samples (inset = 20 µm) show repopulating allo-HPs at the border next to HSCs as compared to PLs-treated sections. Scale bar 100 µm, n = 3/27 per group

Full size image

Overall, these data collectively suggest that the ablation of KCs supports initial survival and translocation of the allo-HPs into the liver injured site. Moreover, it also infers that allo-HPs repopulate in the vicinity of HSCs at the injured site, although the underlying mechanism(s) remains yet to be explored.

Initial innate immune response collectively eliminates engrafted allo-HPs at early stages

The early innate immune response is critical for bio-distribution and acceptance of the initial cell graft post-transplantation [29, 56]. Previously, it was demonstrated that the invading granulocytes and leukocytes can infiltrate and kill the transplanted syngeneic hepatocytes [15]. Based on this fact, we next sought to investigate whether the survival of allo-HPs is affected by the initial innate immune response in the context of sustained inflammation after CI. For this purpose, we depleted KCs 24 h before induction of CI, and injected allo-HPs 6 h post-CI. Samples were collected 24 h post-transplantation (as shown in Additional file 1: Fig. S2A). The immunostaining (with CK19 marker for portal vein) revealed that while PLs-treated sections at 24 h post-transplantation were completely devoid of allo-HPs, the CLs-treated ones had a considerable number of allo-HPs mainly localized into the portal spaces (Additional file 1: Fig. S2B–D). Besides, the allo-HPs were observed to be protruding out from the CK19+ portal spaces (Additional file 1: Fig. S2E). These results suggested that the transplanted cells navigate the injured site through the portal vein.

Our above-described data in Fig. 2 indicated the presence of abundantly invading neutrophils into the injured site post-CI. To further explore whether neutrophils may affect the survival of allo-HPs post-transplantation, we carried out the depletion of neutrophils (by anti-Ly6G antibody) and KCs (PLs/CLs treatments) in two independent but parallel experiments. The experimental design of transplantation and samples collection is represented in Fig. 7A. The depletion of the neutrophils was confirmed by FACS analysis of the samples from peripheral blood (Additional file 1: Fig. S3). The F4/80+ and αSMA+ immunostaining of the sections treated with anti-Ly6G antibody highlighted an evident distribution of allo-HPs at the periphery of the portal spaces, as compared to absolute absence in case of isotype sections (Fig. 7B–E). To further clarify whether the existence of allo-HPs in the anti-Ly6g-treated samples is of the virtue of neutrophils, we analyzed CLs-treated sections by immunostaining of KCs (F4/80+) and HSCs (αSMA+). We found that allo-HPs were relatively more abundant and restricted to the portal spaces (in the form of clusters) as compared to isotype/PL and anti-Ly6G-treated sections (Fig. 7F, G, insets). The abundance of allo-HPs in CLs-treated samples, in comparison to anti-Ly6G ones, suggested the pronounced role of KCs in the elimination of transplanted cells (Fig. 7D–E). Altogether, these data suggest that initial innate immune response may collectively eliminate the transplanted allo-HPs in liver injury.

Fig. 7
figure 7

Initial innate immune response collectively eliminate engrafted allo-HPs at early stages. A Experimental design: anti-Ly6G and CLs/PLs were injected 24 h before CI, whereas allo-HPs were engrafted 6 h post-CI. The samples were collected post-24 h allo-HPs engraftment. B Representative images of sham-treated samples post-transplantation. C Isotype—or PLs-treated liver samples are presented. D, E Anti-Ly6G-treated samples representing few allo-HPs at the injured site. F, G CLs-treated samples representing substantially accumulated allo-HPs as compared to D and E. Scale bar 100 µm (inset = 50 µm), n = 3/27

Full size image

Discussion

We previously demonstrated our strategy to protect transplanted liver progenitor cells driven from embryonic stem cells to escape the adoptive T cell response by ectopic expression of the CTLA4-Ig and PD-L1 molecules [57]. In this study, we mainly emphasize how innate immune cells, particularly the KCs, regulate the translocation and survival of the transplanted cells after a predefined liver injury.

We induced parenchymal liver damage to generate a niche to synergize liver inflammation and regeneration for the homing of the immune as well as transplanted cells; the model which is based on our previous report [34]. We first defined the timeline for the recruitment of the circulating myeloid cells (neutrophils and monocytes) and KCs, before the transplantation of the allo-HPs, to elaborate on how these cell types may modulate the survival of the transplanted cells. Our results implicate a potential coordinated activation of the post-injury cellular network characteristics of liver injury. For instance, given the integral features of acute inflammation [58], an initial transient upregulation in the levels of liver enzymes ALT/AST, as well as IL-6 and IL-10 cytokines, was considerably diminished within 12 h. Interestingly, despite parameters of acute liver injury being downregulated, we found a marked induction of MCP-1, which is a potent chemokine for the infiltration of the myeloid cells [48]. In turn, a rapid enrichment of the circulating myeloid cells (neutrophils/monocytes) was observed into the injured site after injury (Fig. 2). This is in accordance with a previous report where the fluctuating infiltration of these leucocyte subpopulations was demonstrated to be collectively participating and shifting the inflammatory microenvironment into the tissue remodeling niche [59].

The infiltration of the immune cells plays a key role in determining the viable outcome of wound repair. In the case of the injured liver tissue repair, it nevertheless particularly remains the concerted action of the KCs and HSCs [34]. We found both cell types were consistently enriched at the invasive edge of the injured site (Fig. 3A, D). Although not deeply explored here, the KCs-mediated recruitment of HSCs that we observed in this study seems to be an important factor in promoting wound healing (consistent with our previously reported findings in [34]). Besides HSCs, we also found that KCs depletion may essentially modulate the monocyte recruitment at the injured site (Fig. 4B, C), hinting that a possible cellular crosstalk between KCs and monocytes might exist post-injury. Indeed, monocytes and KCs have been reported to play an essential role during tissue repair [60]. Upon liver injury, KCs abundantly produce MCP-1 or CCL2 that especially recruit monocytes from the bone marrow as demonstrated in the choline-deficient, ethionine-supplemented diet model of liver injury and regeneration [60].

Extending our investigations to determine the fate of allo-HPs in the sinusoids, our data indicated that 72–96 h could be the most appropriate time slot for studying the potential impact of KCs (Fig. 3A, B) on transplanted cells. It is well acknowledged that the post-transplantation perturbation in the sinusoids temporarily occludes the blood flow which further aggravates the inflammation and liver injury by the activation of the KCs [30]. Animal studies have demonstrated that hepatocytes upon injection into the liver become trapped in sinusoids, leading to portal hypertension and ischemia–reperfusion injury [15]. The majority of infused hepatocytes remain trapped in the portal spaces and sinusoids, where they are eliminated by the innate immune system, including KCs and granulocytes [23]. In this context, the rapid mobilization of the KCs in the sinusoid and then colocalization with, and clearance of, the allo-HPs were not surprising (Fig. 5E). Interestingly, the elimination of the KCs demonstrated an accelerated translocation and integration of transplanted cells at the injured site (Fig. 6), which further substantiates the role of KCs in clearing transplanted cells in the sinusoidal areas. This appears to be in agreement with a previous report where the activation of KCs delayed the integration of the transplanted cells in the liver [16].

Our data further highlighted the post-transplantation events after KCs elimination. Indeed, one of the key obstacles for the transplanted cells is survival and proliferation in the host parenchyma [61], as engrafted cells incapable of integration are rapidly cleared from the sinusoids [30]. Notably, we observed that majority of transplanted cells that escaped the deleterious effects in the sinusoids were found to be concentrated and repopulated at the injured site (adjacent to the HSCs) in a time-dependent manner (Fig. 6F, inset). This, of course, is consistent with the previously reported findings where the HSCs were demonstrated to favor the engraftment of transplanted hepatocytes in the host liver [55, 62].

Moreover, this study advances our knowledge about the implication of the cumulative innate immune response before the allo-HPs are integrated into the liver parenchyma. A previous study has demonstrated that over 70% of the syngeneic transplanted cells are rejected due to sinusoidal effects [30]. In fact, allogeneic stem cells possess the least immune-privileged properties as compared to syngeneic cells [63]. They are mainly destroyed by the subsequent adaptive immune response once they are integrated into the liver architecture [64, 65]. However, both allogeneic and syngeneic transplanted liver cells may be targeted by the innate immune system in vitro [66, 67]. Consistently, our confocal studies demonstrated that neutrophils and KCs are the predominant effectors in the allogeneic cell rejection 24 h post-transplantation. Thus, the depletion of neutrophils and KCs essentially eliminated the pro-inflammatory response that is critical for the survival and homing of the transplanted cells (Fig. 7). This, in addition to further substantiating the role of neutrophils and KCs in the elimination of the allogeneic cells, provided a proof-of-concept validation for a previously established notion that the transplantation-induced inflammation is driven by neutrophils and KCs [23].

Conclusion

This work clearly defines the role of neutrophils and KCs in the survival of allogeneic cells post-transplantation. In particular, we have shown that KCs depletion enables better translocation and homing of the transplanted cells at the injured site. Although the exact underlying mechanisms that determine that how the post-transplantation inflammatory microenvironment of the liver may impede cell engraftment remain obscure, the overall inflammatory responses demonstrated here as part of liver injury may aid in defining the organ-specific changes following cell transplantation and the subsequent cell-based therapy.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article.

Abbreviations

CI:

Cryo injury

KCs:

Kupffer cells

allo-HPs:

Allogeneic hepatic progenitors

CL:

Clodronate liposomes

PL:

PBS liposomes

OLT:

Orthotopic liver transplantation

HSCs:

Hepatic stellate cells

IL-6:

Interleukin-6

IL-10:

Interleukin-10

MCP-1:

Monocyte chemoattractant protein-1

IFNγ:

Interferon gamma

ALT:

Alanine aminotransferase

AST:

Aspartate transaminase

αSMA:

Alpha smooth muscle actin

IHC:

Immunohistochemistry

References

  1. Adams DH, et al. Mechanisms of immune-mediated liver injury. Toxicol Sci. 2010;115(2):307–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wu Z, et al. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010;30(6):782–94.

    Article  CAS  PubMed  Google Scholar 

  3. Terpstra OT, et al. Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med. 1988;319(23):1507–11.

    Article  CAS  PubMed  Google Scholar 

  4. Todo S, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 1991;13(4):619–26.

    CAS  PubMed  Google Scholar 

  5. Kumar S, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1990;11(2):159–64.

    Article  CAS  PubMed  Google Scholar 

  6. Strom SC, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 1997;63(4):559–69.

    Article  CAS  PubMed  Google Scholar 

  7. Fox IJ, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338(20):1422–6.

    Article  CAS  PubMed  Google Scholar 

  8. Hansel MC, et al. The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol. 2014;62:1–23.

    Article  Google Scholar 

  9. Sokal EM. Treating inborn errors of liver metabolism with stem cells: current clinical development. J Inherit Metab Dis. 2014;37(4):535–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Vacanti JP, Kulig KM. Liver cell therapy and tissue engineering for transplantation. Semin Pediatr Surg. 2014;23(3):150–5.

    Article  PubMed  Google Scholar 

  11. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation. 2006;82(4):441–9.

    Article  PubMed  Google Scholar 

  12. Kakinuma S, Nakauchi H, Watanabe M. Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J Gastroenterol. 2009;44(3):167–72.

    Article  PubMed  Google Scholar 

  13. Dhawan A, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol. 2010;7(5):288–98.

    Article  PubMed  Google Scholar 

  14. Iansante V, et al. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res. 2018;83(1–2):232–40.

    Article  CAS  PubMed  Google Scholar 

  15. Joseph B, et al. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology. 2002;123(5):1677–85.

    Article  PubMed  Google Scholar 

  16. Hong IH, et al. Inhibition of kupffer cell activity improves transplantation of human adipose-derived stem cells and liver functions. Cell Transplant. 2013;22(3):447–59.

    Article  PubMed  Google Scholar 

  17. Ghanem LY, et al. Liver macrophage depletion ameliorates the effect of mesenchymal stem cell transplantation in a murine model of injured liver. Sci Rep. 2019;9(1):35.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  18. Olszewski WL. Intravascular transplantation–allografts in blood stream are destroyed by granulocytes and not lymphocytes. Transplant Proc. 1994;26(6):3472.

    CAS  PubMed  Google Scholar 

  19. Bennet W, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000;105(2):125–33.

    Article  CAS  PubMed  Google Scholar 

  20. Gustafson EK, et al. The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation. 2011;91(6):632–8.

    Article  CAS  PubMed  Google Scholar 

  21. Lee CA, et al. Instant blood-mediated inflammatory reaction in hepatocyte transplantation: current status and future perspectives. Cell Transplant. 2016;25(7):1227–36.

    Article  PubMed  Google Scholar 

  22. Ozmen L, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes. 2002;51(6):1779–84.

    Article  CAS  PubMed  Google Scholar 

  23. Krohn N, et al. Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells. Gastroenterology. 2009;136(5):1806–17.

    Article  CAS  PubMed  Google Scholar 

  24. Dresske B, et al. Spontaneous tolerance: experience with the rat liver transplant model. Hum Immunol. 2002;63(10):853–61.

    Article  CAS  PubMed  Google Scholar 

  25. Guha C, et al. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias. Am J Nephrol. 2005;25(2):161–70.

    Article  PubMed  Google Scholar 

  26. Baccarani U, et al. Human hepatocyte transplantation for acute liver failure: State of the art and analysis of cell sources. Transpl Proc. 2005;37(6):2702–4.

    Article  CAS  Google Scholar 

  27. Fitzpatrick E, Mitry RR, Dhawan A. Human hepatocyte transplantation: state of the art. J Intern Med. 2009;266(4):339–57.

    Article  CAS  PubMed  Google Scholar 

  28. Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol. 2015;62(1 Suppl):S157–69.

    Article  CAS  PubMed  Google Scholar 

  29. Oldhafer F, et al. Immunological aspects of liver cell transplantation. World J Transplant. 2016;6(1):42–53.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gupta S, et al. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology. 1999;29(2):509–19.

    Article  CAS  PubMed  Google Scholar 

  31. Katsuda T, et al. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell. 2017;20(1):41–55.

    Article  MathSciNet  CAS  PubMed  Google Scholar 

  32. Pan T, et al. Robust expansion and functional maturation of human hepatoblasts by chemical strategy. Stem Cell Res Ther. 2021;12(1):151.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Pan T, et al. Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy. Stem Cell Res Ther. 2022;13(1):159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Abbas N, et al. Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage. Biochem Biophys Res Commun. 2020;529(2):474–9.

    Article  MathSciNet  CAS  PubMed  Google Scholar 

  35. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174(1–2):83–93.

    Article  PubMed  Google Scholar 

  36. Tran S, et al. Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity. 2020;53(3):627–40.

    Article  CAS  PubMed  Google Scholar 

  37. Seidman JS, et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity. 2020;52(6):1057–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Sakai M, et al. Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain Kupffer cell identity. Immunity. 2019;51(4):655–70.

    Article  MathSciNet  CAS  PubMed  PubMed Central  Google Scholar 

  39. van der Tuin SJL, et al. Lipopolysaccharide lowers cholesteryl ester transfer protein by activating F4/80(+)Clec4f(+)Vsig4(+)Ly6C(-) Kupffer cell subsets. J Am Heart Assoc. 2018;7(6):e008105.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Yang CY, et al. CLEC4F is an inducible C-type lectin in F4/80-positive cells and is involved in alpha-galactosylceramide presentation in liver. PLoS ONE. 2013;8(6): e65070.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  41. Dory D, et al. Generation and functional characterization of a clonal murine periportal Kupffer cell line from H-2Kb -tsA58 mice. J Leukoc Biol. 2003;74(1):49–59.

    Article  CAS  PubMed  Google Scholar 

  42. Yona S, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38(1):79–91.

    Article  CAS  PubMed  Google Scholar 

  43. Schulz C, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336(6077):86–90.

    Article  ADS  CAS  PubMed  Google Scholar 

  44. Moynihan KD, et al. Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat Med. 2016;22(12):1402–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Getachew A, et al. SAA1/TLR2 axis directs chemotactic migration of hepatic stellate cells responding to injury. iScience. 2021;24(5):102483.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  46. Viebahn CS, Yeoh GC. What fires prometheus? The link between inflammation and regeneration following chronic liver injury. Int J Biochem Cell Biol. 2008;40(5):855–73.

    Article  CAS  PubMed  Google Scholar 

  47. Karlmark KR, et al. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol. 2008;2(2):233–42.

    Article  CAS  PubMed  Google Scholar 

  48. Baeck C, et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut. 2012;61(3):416–26.

    Article  CAS  PubMed  Google Scholar 

  49. Dong X, et al. Role of macrophages in experimental liver injury and repair in mice. Exp Ther Med. 2019;17(5):3835–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Wen Y, et al. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol. 2021;18(1):45–56.

    Article  CAS  PubMed  Google Scholar 

  51. Yin C, et al. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123(5):1902–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127(1):55–64.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Scott CL, et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. 2016;7:10321.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  54. Benten D, et al. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology. 2005;42(5):1072–81.

    Article  CAS  PubMed  Google Scholar 

  55. Dusabineza AC, et al. Hepatic stellate cells improve engraftment of human primary hepatocytes: a preclinical transplantation study in an animal model. Cell Transplant. 2015;24(12):2557–71.

    Article  PubMed  Google Scholar 

  56. Huang H, et al. Innate immune cells in immune tolerance after liver transplantation. Front Immunol. 2018;9:2401.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Liu J, et al. Repair of acute liver damage with immune evasive hESC derived hepato-blasts. Stem Cell Res. 2020;49: 102010.

    Article  CAS  PubMed  Google Scholar 

  58. Liaskou E, Wilson DV, Oo YH. Innate immune cells in liver inflammation. Mediators Inflamm. 2012;2012: 949157.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair. J Clin Invest. 2019;129(7):2629–39.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Elsegood CL, et al. Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology. 2015;62(4):1272–84.

    Article  CAS  PubMed  Google Scholar 

  61. Guha C, et al. Amplification of engrafted hepatocytes by preparative manipulation of the host liver. Artif Organs. 2001;25(7):522–8.

    Article  CAS  PubMed  Google Scholar 

  62. Enami Y, et al. Hepatic stellate cells promote hepatocyte engraftment in rat liver after prostaglandin-endoperoxide synthase inhibition. Gastroenterology. 2009;136(7):2356–64.

    Article  CAS  PubMed  Google Scholar 

  63. Berglund AK, et al. Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Res Ther. 2017;8(1):288.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Bumgardner GL, et al. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection. Transplantation. 1999;68(4):555–62.

    Article  CAS  PubMed  Google Scholar 

  65. Lakkis FG, Lechler RI, Origin and biology of the allogeneic response. Cold Spring Harb Perspect Med 2013;3(8).

  66. Olszewski WL, Jasklowska-Englisz M, Interewicz B. Hepatocyte transplantation-granulocytes recognize surface of isolated autologous hepatocytes as non-self and destroy them. Transplant Proc. 1997;29(1–2):1113–5.

    Article  CAS  PubMed  Google Scholar 

  67. Olszewski WL, et al. Hepatocyte transplantation–in vitro cytotoxic reaction of autologous granulocytes and mononuclears to isolated hepatocytes. Ann Transplant. 1999;4(3–4):11–6.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the National Key R&D Program of China, China-New Zealand Joint Laboratory on Biomedicine and Health, Guangdong Basic and Applied Basic Research Foundation, Guangzhou Science and Technology Planning Project and Guangzhou Science and Technology Program. NA was previously supported by UCAS fellowship for International PhD students and currently is Research Talent Hub (RTH) postdoc fellow at Centre for Regenerative Medicine and Health (CRMH), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong SAR, China.

Funding

This study was supported by the National Key R&D Program of China (2019YFA0111300), China-New Zealand Joint Laboratory on Biomedicine and Health (2022YFE0210600), Guangdong Basic and Applied Basic Research Foundation (2021A1515220095), Guangzhou Science and technology planning project (202102021138), Guangzhou Science and Technology Program (2023B01J1004). This study was partially funded by the CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicines and Health, Chinese Academy of Sciences.

Author information

Author notes

  1. Nasir Abbas

    Present address: Centre for Regenerative Medicine and Health (CRMH), Hong Kong Institute of Science and Innovation, Chinese Academy of Sciences, Hong Kong, Hong Kong SAR, China

Authors and Affiliations

  1. Center for Health Research, Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China

    Nasir Abbas, Kai You, Feima Wu, Xinping Huang, Yan Chen & Yinxiong Li

  2. Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China

    Yan Chen & Yinxiong Li

  3. CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China

    Yan Chen & Yinxiong Li

  4. Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, Guangdong Province, China

    Tingcai Pan

  5. State Key Laboratory of Respiratory Disease, Guangzhou, 510000, China

    Yinxiong Li

  6. China-New Zealand Joint Laboratory of Biomedicine and Health, Guangzhou, 510530, China

    Yinxiong Li

  7. Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA

    Anteneh Getachew

  8. Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, 10016, USA

    Muzammal Hussain

Authors
  1. Nasir Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai You
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anteneh Getachew
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Feima Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Muzammal Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xinping Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tingcai Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yinxiong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NA conceived and carried out this work. YK and AG assisted with the animal experiments. NA performed the experiments and analyzed the data. YK, AG, FW, MH, XH, TP and YC provided technical support and analyzed the data together with NA. NA and MH wrote and revised the manuscript. YL directed the study, critically revised and contributed to manuscript approval. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Yinxiong Li.

Ethics declarations

Ethics approval and consent to participate

Title of the approved project Research on homing efficiency and immune tolerance mechanism of co-transplantation of hepatocytes and hepatic stellate cells in liver injury mouse model. Name of the institutional approval committee or unit Ethics Committee of the Guangzhou Institutes of the Biomedicine and Health, Chinese Academy of Sciences. Approved number N2021046. Date of Approval 8th March 2021.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Fig. S1. KCs ablation supports survival of allo-HPs at the injury site. Fig. S2. Engrafted allo-HPs migrate and navigate to the injury site through portal vein (PV). Fig. S3. Depletion of neutrophils in peripheral blood. Fig. S4. Corresponding full-length immunoblot. Supplementary Table S1: List of primers for qPCR.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abbas, N., You, K., Getachew, A. et al. Kupffer cells abrogate homing and repopulation of allogeneic hepatic progenitors in injured liver site. Stem Cell Res Ther 15, 48 (2024). https://doi.org/10.1186/s13287-024-03656-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13287-024-03656-w

Keywords

Stem Cell Research & Therapy

ISSN: 1757-6512